173 related articles for article (PubMed ID: 25124639)
41. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
[TBL] [Abstract][Full Text] [Related]
42. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
43. Geridonin, a novel derivative of oridonin, inhibits proliferation of MGC 803 cells both in vitro and in vivo through elevating the intracellular ROS.
Wang SQ; Wang C; Wang JW; Yang DX; Wang R; Wang CJ; Li HJ; Shi HG; Ke Y; Liu HM
J Pharm Pharmacol; 2017 Feb; 69(2):213-221. PubMed ID: 28028809
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells.
Li Y; Zhang P; Qiu F; Chen L; Miao C; Li J; Xiao W; Ma E
Life Sci; 2012 Jun; 90(25-26):962-7. PubMed ID: 22634579
[TBL] [Abstract][Full Text] [Related]
45. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
46. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.
Ma YC; Su N; Shi XJ; Zhao W; Ke Y; Zi X; Zhao NM; Qin YH; Zhao HW; Liu HM
Toxicol Appl Pharmacol; 2015 Jan; 282(2):227-36. PubMed ID: 25450480
[TBL] [Abstract][Full Text] [Related]
47. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH
Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
[TBL] [Abstract][Full Text] [Related]
48. ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells.
Cai DT; Jin H; Xiong QX; Liu WG; Gao ZG; Gu GX; Qiu YH
Mol Cell Biochem; 2013 Jul; 379(1-2):161-9. PubMed ID: 23580093
[TBL] [Abstract][Full Text] [Related]
49. Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao.
Li D; Han T; Xu S; Zhou T; Tian K; Hu X; Cheng K; Li Z; Hua H; Xu J
Molecules; 2016 Apr; 21(5):. PubMed ID: 27144553
[TBL] [Abstract][Full Text] [Related]
50. Totarol, a natural diterpenoid, induces selective antitumor activity in SGC-7901 human gastric carcinoma cells by triggering apoptosis, cell cycle disruption and suppression of cancer cell migration.
Xu T; Huang L; Liu Z; Ma D; Zhang G; Ning X; Lu X; Liu H; Jiang B
J BUON; 2019; 24(2):686-692. PubMed ID: 31128024
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of AP-1 gene expression is an initial event in the oridonin-mediated inhibition of colorectal cancer: studies in vitro and in vivo.
Jin H; Tan X; Liu X; Ding Y
J Gastroenterol Hepatol; 2011 Apr; 26(4):706-15. PubMed ID: 21418301
[TBL] [Abstract][Full Text] [Related]
52. MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.
Zhu Y; Jiang H; Zhang C; He QJ; Yang B; Li LJ; Zhu H
Pharmazie; 2009 Dec; 64(12):823-8. PubMed ID: 20095141
[TBL] [Abstract][Full Text] [Related]
53. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway.
Yu RX; Hu XM; Xu SQ; Jiang ZJ; Yang W
Eur J Pharmacol; 2011 Apr; 657(1-3):10-9. PubMed ID: 21187083
[TBL] [Abstract][Full Text] [Related]
54. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line.
Qi X; Zhang D; Xu X; Feng F; Ren G; Chu Q; Zhang Q; Tian K
Int J Nanomedicine; 2012; 7():1793-804. PubMed ID: 22619528
[TBL] [Abstract][Full Text] [Related]
55. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action.
Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F
Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862
[TBL] [Abstract][Full Text] [Related]
56. Antiangiogenic effects of oridonin.
Tian L; Xie K; Sheng D; Wan X; Zhu G
BMC Complement Altern Med; 2017 Apr; 17(1):192. PubMed ID: 28376864
[TBL] [Abstract][Full Text] [Related]
57. Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action.
Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Pan XL; Li MQ; Lin Q
J Int Med Res; 2004; 32(6):617-25. PubMed ID: 15587755
[TBL] [Abstract][Full Text] [Related]
58. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.
Ikezoe T; Chen SS; Tong XJ; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1187-93. PubMed ID: 12964003
[TBL] [Abstract][Full Text] [Related]
59. Studies on the cell-immunosuppressive mechanism of Oridonin from Isodon serra.
Liu J; Yang F; Zhang Y; Li J
Int Immunopharmacol; 2007 Jul; 7(7):945-54. PubMed ID: 17499197
[TBL] [Abstract][Full Text] [Related]
60. Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells.
Li Y; Wang Y; Wang S; Gao Y; Zhang X; Lu C
Med Oncol; 2015 Jan; 32(1):365. PubMed ID: 25491140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
